期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非甾体类抗炎药的不良反应 被引量：6

下载PDF
导出
摘要 简要介绍非甾体类抗炎药的临床应用及不良反应。
作者 夏哲林 陈赛贞 林佳苗 章欣
机构地区 浙江台州市中心医院药剂科
出处 《海峡药学》 2011年第6期262-263,共2页 Strait Pharmaceutical Journal
关键词 非甾体类抗炎药 解热镇痛抗炎药 不良反应
分类号 R927.3 [医药卫生—药学] R969.4 [医药卫生—药理学]
  • 相关文献

参考文献21

  • 1施桂英.从环氧合酶的研究进展评价当今的非甾体抗炎药[J].中华内科杂志,2002,41(12):857-859. 被引量：16
  • 2Hawkey CJ. COX-2 Inhibltors[J].Lancet, 1999, 353 : 307.
  • 3Warner TD, Giulianl F, Vojnovic l, et al. Nonsteroid drug selectivitiesfor cyclo-oxygenase-I rather than cyclo-oxygenase-2 are associatedwith human gastrointestinal toxicity: A full in vitro analysis [J]. ProcNatl Acad Sci USA 1999, 96:7563.
  • 4Moorghen M, Orde M,.Finney KJ, et al. Sulindac enhances cell prolif- eration in DMH-treated mouse colonic mucoses [J]. Cell prolif, 1998, 31(2):59.
  • 5Kohli M, Yu J, Seaman C, et al. SMAC/Diablo-dependent apoptosis induced by nonsteroidal anti-inflammatory drugs (NSAIDs) in colon cancer cells[J].Proc Natl Acad Sci USA, 2004, 101(48) : 16897.
  • 6Yang Z, Hollande F, Pialdwin GS, et al. Blockade of long chain fattyacid oxidation by non-steroidal anti-inflammatory drugs may contributeto inhibition of proliferation of human colorectal carcinoma [J]. Cancer Let, 1998, 124(2) : 187.
  • 7Rodriguez-Burford c, Barnes MN, OelschIager DK, et al. Effects ofNonsteroidal Antil-inflammatory agents (NSAIDs) on ovarian carcino-ma cell lines: preclinical evaluation of NSAIDs as chemo preventive a-gents[J]. Clin Cancer Res, 2002, 8 (1) : 202.
  • 8Slattery ML, Samowite W, Hoffman M. Aspirin, NSAIDs, and colorec-tal caner: possible involvement in an insulin-related pathway [J]. Cancer Epidemiol Biornarkers Prey, 2004, 13(4):538.
  • 9Goodin S, Shill SJ. NSAIDs for the chemoprevention of oral cancer: promise of pessimism [J]. Clin Cancer Res, 2004, 10(3) :1561.
  • 10Secko D. Can NSAIDs contribute to Alzheimer sdisease[J]. CMAJ, 2005,172(13) :1677.

二级参考文献33

  • 1吴健鸿,曾繁典.尼美舒利肝不良反应再评价[J].药物流行病学杂志,2005,14(3):144-147. 被引量：12
  • 2李林,王育琴.主要作用于中枢神经系统的药物[M]//陈新谦,金有豫,汤光.新编药物学.第15版.北京:人民卫生出版社,2003:221-222.
  • 3Ristimaki A,Sivula A,Lundin J,et al.Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer[J].Cancer Res,2002,62(3):632-635.
  • 4Fermandina G,Lauriola L,Distefano MG,et al.Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients[J].J Clin Oncol,2002,20(4):973-981.
  • 5Gallo O,Franchi A,Magnelli L,et al.Cyclooxygenase-2 pathway correlates with VEGF expression in head and neek cancer.Implications for tumor angiogenesis and metastasis[J].Neoplasia,2001,3(1):53-61.
  • 6Raju U,Nakata E,Yang P,et al.In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme:mechanistic considerations[J].Int J Radiat Oncol BiolPhys,2002,54(53):886-894.
  • 7Lang S,Lauffer L,Clausen C,et al.Impaired monocyte function in cancer patients:restoration with a cyclooxygenase-2 inhibitor[J].Faseb J,2003,17 (2):286-288.
  • 8Johnson AJ,Hsu AL,Lin HP,et al.The cyclooxygenase-2 inhibitor celecoxib perturbs intarcellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases:a plausible link with its anti-tumor effect and cardiovascular risks[J].Biochem J,2002,366(Pt 3):831-837.
  • 9Kim SH,Song SH,Kim SG et al.Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target[J].J Cancer Res Clin Oncol,2004,130(9):551-560.
  • 10Zhu J,Huang JW,Tseng PH,et al.From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors[J].Cancer Res,2004,64(12):4309-4318.

共引文献61

同被引文献44

引证文献6

二级引证文献7

海峡药学
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部